Gables Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.67M | Sell |
3,326
-500
| -13% | -$240K | 0.6% | 42 |
|
|
2026
Q1 | $1.88M | Sell |
3,826
-20
| -0.5% | -$10.9K | 0.8% | 37 |
|
|
2025
Q4 | $2.23M | Buy |
3,846
+85
| +2% | +$48.1K | 0.94% | 29 |
|
|
2025
Q3 | $1.82M | Buy |
3,761
+2,674
| +246% | +$1.24M | 0.78% | 36 |
|
|
2025
Q2 | $441K | Hold |
1,087
| – | – | 0.21% | 86 |
|
|
2025
Q1 | $541K | Hold |
1,087
| – | – | 0.27% | 74 |
|
|
2024
Q4 | $565K | Hold |
1,087
| – | – | 0.27% | 71 |
|
|
2024
Q3 | $672K | Buy |
1,087
+12
| +1% | +$7.1K | 0.34% | 64 |
|
|
2024
Q2 | $594K | Hold |
1,075
| – | – | 0.31% | 64 |
|
|
2024
Q1 | $625K | Hold |
1,075
| – | – | 0.34% | 63 |
|
|
2023
Q4 | $571K | Hold |
1,075
| – | – | 0.35% | 63 |
|
|
2023
Q3 | $544K | Hold |
1,075
| – | – | 0.38% | 59 |
|
|
2023
Q2 | $561K | Hold |
1,075
| – | – | 0.37% | 61 |
|
|
2023
Q1 | $620K | Buy |
1,075
+8
| +0.7% | +$4.51K | 0.43% | 55 |
|
|
2022
Q4 | $588K | Hold |
1,067
| – | – | 0.43% | 56 |
|
|
2022
Q3 | $541K | Hold |
1,067
| – | – | 0.43% | 53 |
|
|
2022
Q2 | $580K | Hold |
1,067
| – | – | 0.44% | 55 |
|
|
2022
Q1 | $630K | Hold |
1,067
| – | – | 0.4% | 57 |
|
|
2021
Q4 | $712K | Hold |
1,067
| – | – | 0.42% | 57 |
|
|
2021
Q3 | $610K | Sell |
1,067
-40
| -4% | -$22K | 0.4% | 62 |
|
|
2021
Q2 | $558K | Hold |
1,107
| – | – | 0.38% | 66 |
|
|
2021
Q1 | $505K | Hold |
1,107
| – | – | 0.28% | 81 |
|
|
2020
Q4 | $516K | Hold |
1,107
| – | – | 0.3% | 76 |
|
|
2020
Q3 | $489K | Sell |
1,107
-50
| -4% | -$20.7K | 0.32% | 72 |
|
|
2020
Q2 | $419K | Hold |
1,157
| – | – | 0.29% | 76 |
|
|
2020
Q1 | $328K | Buy |
1,157
+54
| +5% | +$17K | 0.27% | 79 |
|
|
2019
Q4 | $358K | Sell |
1,103
-110
| -9% | -$33.4K | 0.24% | 87 |
|
|
2019
Q3 | $353K | Hold |
1,213
| – | – | 0.25% | 88 |
|
|
2019
Q2 | $356K | Hold |
1,213
| – | – | 0.29% | 72 |
|
|
2019
Q1 | $332K | Hold |
1,213
| – | – | 0.27% | 80 |
|
|
2018
Q4 | $271K | Hold |
1,213
| – | – | 0.24% | 87 |
|
|
2018
Q3 | $296K | Hold |
1,213
| – | – | 0.23% | 90 |
|
|
2018
Q2 | $251K | Buy |
1,213
+20
| +2% | +$4.25K | 0.2% | 90 |
|
|
2018
Q1 | $246K | Buy |
+1,193
| New | +$250K | 0.22% | 90 |
|
Other funds holding TMO
Gables Capital Management's TMO Position: Q2 2026 in Review
Gables Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, selling an estimated $240K and leaving 3,326 shares worth $1.67M. The position accounts for 0.6% of the portfolio, ranked #42.
Gables Capital Management first reported a position in TMO in Q1 2018 and has held it in 34 quarters since. The position peaked at $2.23M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Gables Capital Management held 3,326 shares of Thermo Fisher Scientific worth $1.67M as of Q2 2026.
- Gables Capital Management sold 500 Thermo Fisher Scientific shares in Q2 2026, an estimated $240K.
- Thermo Fisher Scientific made up 0.6% of Gables Capital Management's portfolio in Q2 2026, its #42 holding.
- Gables Capital Management first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 34 quarters since.
- Gables Capital Management's Thermo Fisher Scientific position peaked at $2.23M in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Gables Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.